New drug shown to improve bone growth in children with achondroplasia in global phase III trial
A phase three global clinical trial led by the Murdoch Children's Research Institute (MCRI) has shown a new drug boosts bone growth in children born with achondroplasia, the most common type of dwarfism.
Sep 7, 2020
0
12